CN108752289B - Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt - Google Patents

Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt Download PDF

Info

Publication number
CN108752289B
CN108752289B CN201811052610.0A CN201811052610A CN108752289B CN 108752289 B CN108752289 B CN 108752289B CN 201811052610 A CN201811052610 A CN 201811052610A CN 108752289 B CN108752289 B CN 108752289B
Authority
CN
China
Prior art keywords
ethylbenzothiazoline
sulfonic acid
dinitrobis
diammonium salt
synthesizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811052610.0A
Other languages
Chinese (zh)
Other versions
CN108752289A (en
Inventor
余书强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI HANHONG TECHNOLOGY CO.,LTD.
Original Assignee
Nanjing Apt Biopharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Apt Biopharmaceutical Co ltd filed Critical Nanjing Apt Biopharmaceutical Co ltd
Priority to CN201811052610.0A priority Critical patent/CN108752289B/en
Publication of CN108752289A publication Critical patent/CN108752289A/en
Application granted granted Critical
Publication of CN108752289B publication Critical patent/CN108752289B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention provides a synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt (ABTS), belonging to the field of organic synthesis. The 2-hydroxybenzothiazole firstly reacts with 2-bromoethane to generate 3-ethylbenzothiazole-2-ketone, then reacts with hydrazine hydrate to generate 2,2' -azino bis (3-ethylbenzothiazoline), then reacts with concentrated sulfuric acid for sulfonation to generate a compound 2,2' -azino bis (3-ethylbenzothiazoline-6-sulfonic acid), and finally reacts with ammonia gas to generate salt so as to obtain 2,2' -biamino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt. The method has the advantages of cheap and easily obtained raw materials, simple and convenient operation, mild reaction conditions and high yield.

Description

Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
Technical Field
The invention relates to the technical field of chemical synthesis, in particular to a synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt (ABTS).
Technical Field
The 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt (ABTS) can be used for biochemical research, free chlorine spectral reagent, chromogenic substrate of enzyme-linked immunosorbent assay, and substrate of peroxidase for ELISA experiment. An ABTS method, namely Total Antioxidant Capacity Assay Kit with ABTS method, T-AOC Assay Kit for short, is a Kit which adopts ABTS as a color developing agent and can detect the Total Antioxidant Capacity of various body fluids such as blood plasma, blood serum, saliva, urine and the like, lysate such as cells or tissues and the like, plant or Chinese herbal medicine extract or various Antioxidant (Antioxidant) solutions. At present, few reports on the literature about the synthesis of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt (ABTS) are provided, and only the literature showsSynthetic Communications, 2014, vol. 44, # 24, p. 3630–3636In addition to the complete reports, other reports only relate to different synthesis methods of intermediates in the synthesis process of ABTS, and no specific detailed reports of ABTS exist. At present, ABTS is expensive, the synthesis route is limited, and the search for a new optimized synthesis method of ABTS still has great significance, which is also the intention of chemical substance methodology per se.
Disclosure of Invention
The invention aims to provide a method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS).
The invention provides the following synthesis technical scheme, a synthesis method of 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), and the synthesis route of the invention is as follows:
Figure 307975DEST_PATH_IMAGE001
the method comprises the following steps:
dissolving 2-hydroxybenzothiazole and 2-bromoethane in an organic solvent, and reacting under an alkaline condition to obtain 3-ethylbenzothiazole-2-ketone.
And secondly, dissolving 3-ethylbenzothiazole-2-ketone and hydrazine hydrate in an organic solvent, and heating and refluxing the mixture under the catalysis of hydrochloric acid to react to obtain the 2,2' -dinitrobis (3-ethylbenzothiazoline).
And thirdly, dissolving 2,2 '-dinitrobis (3-ethylbenzothiazoline) in 10% fuming sulfuric acid, and reacting under the ice-water bath condition to obtain 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid).
And fourthly, dissolving the 2,2 '-dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) in an organic solvent, and reacting with ammonia to obtain 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt.
In the method, the organic solvent in the first step is selected from tetrahydrofuran or acetonitrile; in the second step and in the fourth step, the organic solvent is selected from methanol or ethanol.
In the first step of the method, the molar ratio of 2-hydroxybenzothiazole to 2-bromoethane to alkali is 1: 1.1-1.5: 1-1.5.
In the first step of the method, the used alkali is sodium hydroxide or potassium hydroxide, and the reaction temperature is from room temperature to solvent reflux.
According to the method, after the first-step reaction is finished, hydrazine hydrate can be directly added for the second-step reaction without treatment.
In the second step of the method, the molar ratio of the 3-ethylbenzothiazole-2-ketone, the hydrazine hydrate and the hydrochloric acid is 1: 0.5-0.55: 0.1-0.2.
In the third step of the method, the mass ratio of 2,2' -dinitrobis (3-ethylbenzthiazoline) and 10% fuming sulfuric acid is 1: 5-10.
In the fourth step of the method, ammonia gas can be introduced or ammonia water can be added for reaction.
In the fourth step of the method, the molar ratio of the 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) to the ammonia is 1: 2-4.
The invention has the beneficial effects that: the novel method for synthesizing the 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diamine salt (ABTS) has the advantages of low cost, high yield, excellent synthetic route and the like, and the pilot production is already carried out, and a large amount of pilot production is carried out.
Detailed Description
The present invention is described in detail below with reference to specific examples, which are intended to be illustrative of the operation of the present invention and are not intended to be limiting.
Example 1
(1) 2-hydroxybenzothiazole (1mol, 151 g), 2-bromoethane (1.1mol, 120 g) and potassium hydroxide (1mol, 56 g) were dissolved in 2L of tetrahydrofuran, stirred at 0 ℃ for reaction for 1 hour, then reacted at room temperature for 2 hours, after the reaction was completed, the tetrahydrofuran solvent was removed by spinning, 2L of ethyl acetate was added, washed twice with water, dried over anhydrous sodium sulfate, then ethyl acetate was spun off, and crystallized from methyl t-butyl ether to give 150 g of 3-ethylbenzothiazol-2-one in 84% yield. HNMR (DMSO-d 6, 400MHz): 7.67-7.60 (m, 1H), 7.41-7.27 (m, 2H), 7.23-7.14 (m, 1H), 3.97(q, 2 H), 1.19(t,3H).
(2) 3-ethylbenzothiazol-2-one (1mol, 179 g) obtained in step (1) was dissolved in 1000mL of ethanol, followed by addition of 80% hydrazine hydrate (0.625mol, 31 g), heating and refluxing for 4 hours, and TLC detection showed no reaction. Then concentrated hydrochloric acid (0.12mol, 10mL) is added, stirring is continued, precipitation is gradually generated, reaction is continued for 3 hours, cooling, suction filtration and washing with cold ethanol are carried out, so that 153 g of 2,2' -dinitrobis (3-ethylbenzthiazoline) is obtained, and the yield is 86%. H NMR (DMSO-d 6, 400 MHz): 7.53 (d, 1H), 7.26 (t, 1H), 7.18 (d, 1H), 6.99 (t,1H), 4.05 (q, 2H) , 1.27 (t, 3H).
Directly adding hydrazine hydrate without separation after the first-step reaction to carry out a second-step reaction: dissolving 2-hydroxybenzothiazole (1mol, 151 g), 2-bromoethane (1.1mol, 120 g) and potassium hydroxide (1mol, 56 g) in tetrahydrofuran 2L, stirring and reacting at 0 ℃ for 1 hour, then reacting at room temperature for 2 hours, then adding hydrochloric acid to adjust the mixture to be acidic, adding 80% hydrazine hydrate (0.625mol, 31 g), heating and refluxing to generate a solid, cooling after 4 hours, and performing suction filtration to obtain 140 g of 2,2' -biazobis (3-ethylbenzothiazoline) with the yield of 79%.
(3) Slowly adding the 2,2 '-dinitrobis (3-ethylbenzothiazoline) (1mol, 354.5 g) obtained in the step (2) into 1.8L of 10% fuming sulfuric acid in an ice water bath, stirring to room temperature, reacting for 4 hours, slowly pouring the reaction liquid onto crushed ice, continuously stirring, performing suction filtration to obtain a dark blue-green solid, washing the solid twice with a small amount of water, washing off sulfuric acid contained in the solid, and performing suction filtration to dryness to obtain 510 g of a crude product of the 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid), wherein the yield is 99%. H NMR (DMSO-d 6, 400MHz): 7.73 (s, 2H), 7.52-7.50 (m, 2H), 7.12-7.14 (m, 4H), 4.09 (q, 2H), 1.27 (t, 6H).
(4) Dissolving the 2,2 '-diazobis (3-ethylbenzothiazoline-6-sulfonic acid) (1mol, 515 g) obtained in the step (3) in 5L of methanol to obtain a clear dark green solution, introducing ammonia gas under stirring at room temperature to generate solid, after no more solid is generated, after the reaction is finished, performing suction filtration to obtain 450 g of 2,2' -diazobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt ABTS, performing rotary evaporation to remove part of filtrate methanol to obtain 50 g of ABTS, combining the ABTS and the ABTS, and recrystallizing with water to obtain 460 g with the yield of 84%. H NMR (DMSO-d 6, 400MHz): 7.72 (d, 2H), 7.52-7.50 (m, 2H), 7.12 (d, 10H), 4.06 (q, 4H), 1.27 (t, 6H).
Example 2
(1) 2-hydroxybenzothiazole (1mol, 151 g), 2-bromoethane (1.2mol, 131 g) and sodium hydroxide (1.1mol, 44 g) were dissolved in acetonitrile 2L, stirred at 0 ℃ for 1 hour, then reacted at room temperature for 2 hours, after the reaction was completed, the acetonitrile solvent was removed by spinning, 2L of dichloromethane was added, washed twice with water, dried over anhydrous sodium sulfate, then the dichloromethane was spun off, and crystallized from methyl t-butyl ether to give 153 g of 3-ethylbenzothiazol-2-one in 85% yield.
(2) Dissolving the 3-ethylbenzothiazole-2-ketone (1mol, 179 g) obtained in the step (1) in 1000mL of methanol, adding 80% hydrazine hydrate (0.625mol, 31 g), then adding concentrated hydrochloric acid (0.14mol, 12mL), heating and refluxing for 4 hours, after the reaction is finished, cooling, carrying out suction filtration, and washing with cold methanol to obtain 151 g of 2,2' -dinitrobis (3-ethylbenzothiazoline) with the yield of 85%.
(3) Slowly adding the 2,2 '-diazobis (3-ethylbenzothiazoline) (1mol, 354.5 g) obtained in the step (2) into 1.5L of 10% fuming sulfuric acid in ice water bath, stirring to room temperature for reacting for 6 hours, slowly pouring the reaction liquid onto crushed ice, continuously stirring, performing suction filtration to obtain a dark blue-green solid, washing the solid twice with a small amount of water, washing to remove sulfuric acid contained in the solid, and performing suction filtration to dryness to obtain about 511 g of a crude product of the 2,2' -diazobis (3-ethylbenzothiazoline-6-sulfonic acid), wherein the yield is 99%.
(4) Dissolving the 2,2 '-diazobis (3-ethylbenzothiazoline-6-sulfonic acid) (1mol, 515 g) obtained in the step (3) in 5L of methanol to obtain a clear dark green solution, adding 200 g of 25% ammonia water under stirring at room temperature to generate a solid, stirring for 1-2 hours, removing part of methanol after the reaction is finished, performing suction filtration to obtain 490 g of 2,2' -diazobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt ABTS, and recrystallizing with water to obtain 450 g of a pure product with the yield of 82%.

Claims (7)

1. A method for synthesizing 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt is characterized in that the reaction equation is as follows:
Figure FDA0003271444870000011
comprises the following steps:
dissolving 2-hydroxybenzothiazole and 2-bromoethane in an organic solvent, and reacting under an alkaline condition to obtain 3-ethylbenzothiazole-2-ketone; wherein the organic solvent is selected from tetrahydrofuran or acetonitrile; the molar ratio of 2-hydroxybenzothiazole, 2-bromoethane to base is 1: 1.1-1.5: 1-1.5; the alkali is sodium hydroxide or potassium hydroxide, and the reaction temperature is from room temperature to solvent reflux;
secondly, dissolving 3-ethylbenzothiazole-2-ketone and hydrazine hydrate in an organic solvent, and heating and refluxing the mixture under the catalysis of hydrochloric acid to react to obtain 2,2' -dinitro-bis (3-ethylbenzothiazoline);
dissolving 2,2 '-dinitrobis (3-ethylbenzothiazoline) in 10% fuming sulfuric acid, and reacting in an ice-water bath to obtain 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid);
and fourthly, dissolving the 2,2 '-dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) in an organic solvent, and reacting with ammonia to obtain 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt.
2. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: in the second step and in the fourth step, the organic solvent is selected from methanol or ethanol.
3. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: in the second step, the mol ratio of the 3-ethylbenzothiazole-2-ketone, the hydrazine hydrate and the hydrochloric acid is 1: 0.5-0.55: 0.1-0.2.
4. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: after the first step reaction is finished, hydrazine hydrate is directly added for the second step reaction without separation.
5. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: in the third step, the mass ratio of 2,2' -dinitrobis (3-ethylbenzthiazoline) and 10% fuming sulfuric acid is 1: 5-10.
6. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: in the fourth step, ammonia gas is introduced or ammonia water is added for reaction with ammonia.
7. The method for synthesizing 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt according to claim 1, wherein the method comprises the following steps: in the fourth step, the molar ratio of 2,2' -dinitrobis (3-ethylbenzothiazoline-6-sulfonic acid) to ammonia is 1: 2-4.
CN201811052610.0A 2018-09-10 2018-09-10 Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt Active CN108752289B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811052610.0A CN108752289B (en) 2018-09-10 2018-09-10 Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811052610.0A CN108752289B (en) 2018-09-10 2018-09-10 Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt

Publications (2)

Publication Number Publication Date
CN108752289A CN108752289A (en) 2018-11-06
CN108752289B true CN108752289B (en) 2021-12-03

Family

ID=63967834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811052610.0A Active CN108752289B (en) 2018-09-10 2018-09-10 Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt

Country Status (1)

Country Link
CN (1) CN108752289B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111892554B (en) * 2020-08-10 2022-08-16 苏州亚科科技股份有限公司 Preparation method of 2,2' -biazonitrogen-bis (3-alkylbenzothiazoline-6-sulfonic acid) salt
CN112500411B (en) * 2020-12-14 2023-03-14 南京红太阳生物化学有限责任公司 Preparation method of 1,1 '-ethylene-2, 2' -bipyridyl dichloride salt

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731514A1 (en) * 2005-06-02 2006-12-13 Sandoz AG Process for the preparation of Pramipexole
CN103073522A (en) * 2013-01-14 2013-05-01 江西师范大学 Synthetic method for 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
CN103833674A (en) * 2014-03-13 2014-06-04 杭州师范大学 Method for synthesizing 4-methyl-2-diazanyl benzothiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0670055B2 (en) * 1986-01-06 1994-09-07 住友化学工業株式会社 Imidazopyridine derivative and herbicide containing the same as active ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1731514A1 (en) * 2005-06-02 2006-12-13 Sandoz AG Process for the preparation of Pramipexole
CN103073522A (en) * 2013-01-14 2013-05-01 江西师范大学 Synthetic method for 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
CN103833674A (en) * 2014-03-13 2014-06-04 杭州师范大学 Method for synthesizing 4-methyl-2-diazanyl benzothiazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Two Polymerizable Derivatives of 2,2’-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);Jiangfeng Fei et al.;《Org. Lett.》;20051207;第8卷(第1期);第3-6页 *

Also Published As

Publication number Publication date
CN108752289A (en) 2018-11-06

Similar Documents

Publication Publication Date Title
CN102471305A (en) Method for producing cyclic sulfonic acid ester and intermediate thereof
CN108752289B (en) Synthesis method of 2,2' -hydrazine-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
US9440915B2 (en) Method for preparing methanedisulfonic acid
EP0413064B1 (en) Preparation of 2-phenyl-1, 3-propane diol and its dicarbamate
KR101777474B1 (en) A method for preparing 1,3-prop-1-ene sultone
US7534911B2 (en) Process for the preparation of Isosulphan Blue
EP2674420B1 (en) Method for producing aminophenyl pyrimidinyl alcohol derivative, and synthesis intermediate thereof
CN103159620A (en) Preparation method of 2-hydroxyisophthalic acid
US7109353B2 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl
CN101402589A (en) Synthesis of 2-bromine-4-nitrobenzene ethane nitrile
CN108299466B (en) Improved dolutegravir synthesis method
US7872007B2 (en) Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
CN112321510A (en) Preparation method of 4-bromo-5-methyl-1H-indazole
CN102424651B (en) One prepares the method for 2,7-diacetoxy-9-Fluorenone and 2,7-dihydroxyl-9-Fluorenone
WO2005030738A1 (en) Improved process for the preparation of intermediates useful for the preparation of zonisamide
US4154757A (en) Process for the manufacture of p-hydroxybenzyl cyanide
CN101659612B (en) Selective esterification method
CN105777669B (en) The method that 2 ethyoxyl 5 (the base sulfonyl of 4 methyl piperazine 1) benzoic acid are prepared with gaultherolin
CN110668951B (en) Synthesis process of selegiline hydrochloride
CN117229187B (en) Synthesis method of thioimine ester compound
CN117682974B (en) Preparation method of 2-propionyl-1-pyrroline
CN114685415B (en) Synthesis method of kojic acid dimer
CN114276244B (en) Preparation method of carboxylic acid compound and metal salt derivative thereof
CN114380835B (en) Preparation method of 7- (3,4-dimethoxyphenyl) -2-pyrazole [1,5-A ] pyrimidine carboxylic acid
CN101863834B (en) Preparation method of S-carboxymethyl-5,5-diphenyl-2-thiohydantoin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TA01 Transfer of patent application right

Effective date of registration: 20211122

Address after: 200234 room 705, building 2, No. 245, Jiachuan Road, Xuhui District, Shanghai

Applicant after: SHANGHAI HANHONG TECHNOLOGY CO.,LTD.

Address before: 210000 Building D, No. 606, ningliu Road, Jiangbei new district, Nanjing City, Jiangsu Province

Applicant before: NANJING APT BIOPHARMACEUTICAL Co.,Ltd.

TA01 Transfer of patent application right